HPV Ends Here: Increasing Uptake of the HPV Vaccine

Description

Develop, implement, and evaluate a culturally tailored multilevel intervention to increase uptake of the HPV vaccine among eligible patients ages 10-12 of the University of California, Davis Health Community Physician (UCDH CP) primary care practices using a randomized controlled trial design.

Conditions

HPV Vaccine

Study Overview

Study Details

Study overview

Develop, implement, and evaluate a culturally tailored multilevel intervention to increase uptake of the HPV vaccine among eligible patients ages 10-12 of the University of California, Davis Health Community Physician (UCDH CP) primary care practices using a randomized controlled trial design.

Human Papillomavirus Ends Here: A Multilevel Intervention to Increase Uptake of the HPV Vaccine Among Adolescents

HPV Ends Here: Increasing Uptake of the HPV Vaccine

Condition
HPV Vaccine
Intervention / Treatment

-

Contacts and Locations

Sacramento

University of California Davis Health, Sacramento, California, United States, 95817

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    10 Years to 12 Years

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    Yes

    Collaborators and Investigators

    University of California, Davis,

    Julie HT Dang, PhD, PRINCIPAL_INVESTIGATOR, University of California, Davis

    Study Record Dates

    2026-12-31